C12N 2800/90
Vectors containing a transposable element
C12N2800/90 (Vectors containing a transposable element) appears on 274 US grants and 529 published applications in this corpus.
Search patents in C12N- Granted patents
- 274
- Published applications
- 529
- Assignees
- 288
- Inventors
- 1,015
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1994 | 3 | 0 |
| 1995 | 0 | 0 |
| 1996 | 2 | 0 |
| 1997 | 5 | 0 |
| 1998 | 6 | 0 |
| 1999 | 8 | 0 |
| 2000 | 9 | 0 |
| 2001 | 7 | 0 |
| 2002 | 8 | 8 |
| 2003 | 4 | 12 |
| 2004 | 3 | 15 |
| 2005 | 4 | 7 |
| 2006 | 5 | 20 |
| 2007 | 6 | 8 |
| 2008 | 3 | 9 |
| 2009 | 5 | 8 |
| 2010 | 3 | 23 |
| 2011 | 4 | 15 |
| 2012 | 5 | 7 |
| 2013 | 15 | 9 |
| 2014 | 7 | 10 |
| 2015 | 9 | 23 |
| 2016 | 13 | 17 |
| 2017 | 12 | 22 |
| 2018 | 9 | 16 |
| 2019 | 10 | 23 |
| 2020 | 5 | 25 |
| 2021 | 19 | 34 |
| 2022 | 13 | 44 |
| 2023 | 15 | 41 |
| 2024 | 15 | 49 |
| 2025 | 26 | 45 |
| 2026 | 16 | 39 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compositions and methods for the treatment of hemophilia6 Oct 2026US 12,753,418 B2Poseida Therapeutics, Inc.
- Efficient non-meiotic allele introgression in livestock1 Sep 2026US 12,721,326 B2Tog Technologies, LLC
- Method for high level and stable gene transfer in lymphocytes1 Sep 2026US 12,723,265 B2Julius-Maximilians-UniversitäT WüRzburg
- VHH-containing heavy chain antibody and production thereof7 Jul 2026US 12,673,984 B2Universitätsklinikum Hamburg-Eppendorf
- Self-inactivating transposase plasmids and uses thereof23 Jun 2026US 12,662,685 B2Seattle Children's Hospital
- Targeted insertion via transposition24 Sep 2026US 2026/0286372 A1Donald Danforth Plant Science Center
- Viral and non-viral nanoplasmid vectors with improved production24 Sep 2026US 2026/0286384 A1Aldevron, LLC
- Engineered hypoxia biosensors and methods of using the same3 Sep 2026US 2026/0258441 A1Northwestern University
- Enzymes capable of mediating large-fragment dna integration into mammalian genomes and uses thereof27 Aug 2026US 2026/0250718 A1Yoltech Therapeutics Co., Ltd
- Method for degrading target protein20 Aug 2026US 2026/0242452 A1Inter-University Research Institute Corporation Research Organization of Information and Systems
Most cited
By later US patents
- CRISPR-Cas systems and methods for altering expression of gene products1,186US 8,697,359 B1Massachusetts Institute of Technology · 2014
- CRISPR-Cas systems and methods for altering expression of gene products483US 8,945,839 B2Massachusetts Institute of Technology · 2015
- CRISPR-Cas systems and methods for altering expression of gene products470US 8,771,945 B1Massachusetts Institute of Technology · 2014
- System for in vitro transposition309US 5,965,443 AWisconsin Alumni Research Foundation · 1999
- System for in vitro transposition162US 5,925,545 AWisconsin Alumni Research Foundation · 1999